Altogether, it can be concluded that the expression of immune inhibitory receptors PD1, TIM3 and A2a, is increased during CAR T cell manufacturing process and more importantly, it seems that current CAR T cell production protocols can lead to ex vivo differentiation of CAR T cells into terminally exhausted phenotype especially in cancer patients. This evidence concerns the gene PDCD1 and cancer.